The Silent Epidemic: Why We Are Failing Our Aging Population in the Opioid Crisis
AI-generated image · Bay Street Wire
Opinion: By framing the opioid crisis as a youth-only struggle, we have engineered a silence that leaves Ontario's seniors to suffer and die alone.
For too long, the narrative surrounding the opioid epidemic has been painted in the colors of youth. When politicians and clinicians speak of this crisis, as Dr. Samir Sinha notes in reporting first published by Global News Toronto, the mental image is typically one of young people using illicit substances. But this narrow focus is more than a misconception; it is a dangerous blind spot. We are failing our elders by pretending the crisis stops at middle age, leaving a generation of seniors to navigate a lethal landscape in a silence we have collectively engineered.
Recent data reveals that the crisis is not just reaching older adults—it is accelerating. A report from the Toronto-based Catholic hospital network, Unity Health, describes an “overlooked and evolving crisis.” According to the study, approximately 1 in 350 older Ontarians now has opioid use disorder (OUD), marking a staggering 81 per cent increase since 2017. The numbers are chilling: between 2017 and 2025, the number of adults aged 55 and older seeking care for OUD more than doubled, jumping from 7,116 to 15,231.
We must ask ourselves how we arrived here. Tara Gomes, an epidemiologist and author of the Unity Health report, points to a systemic failure rooted in the 1990s and early 2000s, when opioid prescriptions were handed out at high rates. As those prescriptions waned in the 2010s, a population that had developed OUD decades ago began transitioning to illicit drug supplies to satisfy their needs. We didn't just prescribe these drugs; we created a dependency and then looked away as the patients aged into their 50s and 60s.
The tragedy is compounded by the biological vulnerability of the elderly. Dr. Samir Sinha, in a 2023 report by the National Institute on Ageing, explains that older adults have the highest rates of prescription opioid consumption, as well as the highest rates of mortality, side effects, and overdoses. He notes that aging bodies are less capable of metabolizing medications, and the prevalence of chronic health issues leads to more medications, increasing the risk of dangerous drug interactions.
Yet, the support systems are crumbling. Gomes warns that long-term care homes are understaffed and may lack the capacity to observe treatment doses or ensure safety for those with OUD. Even more heartbreaking is the isolation of those remaining in their own residences. The Unity Health report found that 78 per cent of deaths associated with OUD occurred in the patients' own homes. They are dying in the dark, far from the eyes of a public that believes this is a "youth problem."
The chemicals involved—hydromorphone, oxycodone, codeine, morphine, and methadone—do not discriminate by age. The resulting deaths do. According to the data, opioid-related deaths among older adults climbed from 1.1 per 100,000 in 2013 to 1.8 per 100,000 by 2024. Furthermore, Sinha’s research indicates that roughly three out of every four drug-related deaths among people aged 65 and older are linked to opioids.
It is time to stop treating the senior opioid crisis as a footnote. We need a fundamental shift in how clinicians and policymakers view this epidemic. As Sinha suggests, doctors should be encouraged to explore every alternative to opioids for chronic pain—including exercise, massage therapy, and other medications—before reaching for the prescription pad.
Our elders deserve more than our neglect. If we continue to ignore the evolving nature of this crisis, we are not just failing a demographic; we are betraying the very people who built the society we now struggle to protect.